tiprankstipranks
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market

Ascendis Pharma (ASND) Technical Analysis

467 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Ascendis Pharma’s (ASND) Moving Averages Convergence Divergence (MACD) indicator is 0.77, suggesting Ascendis Pharma is a Sell.
Ascendis Pharma’s (ASND) 20-Day exponential moving average is 132.65, while Ascendis Pharma’s (ASND) share price is $135.81, making it a Buy.
Ascendis Pharma’s (ASND) 50-Day exponential moving average is 133.75, while Ascendis Pharma’s (ASND) share price is $135.81, making it a Buy.

Ascendis Pharma (ASND) Pivot Points

Jul 08, 2024, 01:28 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
128.78
130.90
132.54
134.66
136.30
138.42
140.06
Fibonacci
130.90
132.34
133.22
134.66
136.10
136.98
138.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ascendis Pharma (ASND) Moving Averages

Jul 08, 2024, 01:28 PM
Period
Simple
Exponential
MA5
135.32Buy
134.92Buy
MA10
133.77Buy
133.72Buy
MA20
131.65Buy
132.65Buy
MA50
132.35Buy
133.75Buy
MA100
140.56Sell
133.61Buy
MA200
124.78Buy
121.85Buy
Ascendis Pharma’s (ASND) 10-Day exponential moving average is 133.72, while Ascendis Pharma’s (ASND) share price is $135.81, making it a Buy.
Ascendis Pharma’s (ASND) 100-Day exponential moving average is 133.61, while Ascendis Pharma’s (ASND) share price is $135.81, making it a Buy.
Ascendis Pharma’s (ASND) stock price is $135.81 and Ascendis Pharma’s (ASND) 50-day simple moving average is 132.35, creating a Buy signal.
Ascendis Pharma’s (ASND) stock price is $135.81 and Ascendis Pharma’s (ASND) 100-day simple moving average is 140.56, creating a Sell signal.
Ascendis Pharma’s (ASND) stock price is $135.81 and Ascendis Pharma’s (ASND) 200-day simple moving average is 124.78, creating a Buy signal.

Ascendis Pharma (ASND) Technical Indicators

Jul 08, 2024, 01:28 PM
Name
Value
Implied Action
RSI (14)
55.02
Neutral
STOCH (9,6)
78.65
Neutral
STOCHRSI (14)
81.17
Sell
MACD (12,26)
0.77
Sell
ADX (14)
17.48
Buy
Williams %R
-16.63
Sell
CCI (14)
52.15
Neutral
ATR (14)
5.00
-
Ultimate Oscillator
54.39
Neutral
ROC
6.23
Buy
Ascendis Pharma’s (ASND) Relative Strength Index (RSI) is 55.02, creating a Neutral signal.
Ascendis Pharma’s (ASND) Trend Strength Indicator (ADX) is 17.48, creating a Buy signal.
Ascendis Pharma’s (ASND) Commodity Channel Index (CCI) is 52.15, creating a Neutral signal.
Ascendis Pharma’s (ASND) Price Rate of Change (ROC) is 6.23, creating a Buy signal.

FAQ

Is ASND a Buy, Hold, or Sell?
Based on ASND’s technical indicators, ASND is a Buy.
    What is ASND’s RSI (14)?
    ASND’s RSI (14) is 55.02, which suggests ASND is a Neutral.
      What is ASND’s MACD?
      ASND’s MACD is 0.77, which suggests ASND is a Sell.
        What is ASND’s 5-day moving average?
        ASND’s 5-day moving average is 135.32, which suggests ASND is a Buy.
          What is ASND’s 20-day moving average?
          ASND 20-day moving average is 131.65, which suggests ASND is a Buy.
            What is ASND’s 50-day moving average?
            ASND’s 50-day moving average is 132.35, which suggests ASND is a Buy.
              What is ASND’s 200-day moving average?
              ASND’s 200-day moving average is 124.78, which suggests ASND is a Buy.
                What is ASND’s Williams % R (14)?
                ASND’s Williams % R (14) is -16.63, which suggests ASND is a Sell.
                  What is ASND’s CCI (14)?
                  ASND’s CCI (14) is 52.15, which suggests ASND is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis